PortalPublikationenMolecular genetics in acute myeloid leukemia.

Molecular genetics in acute myeloid leukemia.

Standard

Molecular genetics in acute myeloid leukemia. / Bacher, Ulrike; Schnittger, Susanne; Haferlach, Torsten.

in: CURR OPIN ONCOL, Jahrgang 22, Nr. 6, 6, 2010, S. 646-655.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Bacher, U, Schnittger, S & Haferlach, T 2010, 'Molecular genetics in acute myeloid leukemia.', CURR OPIN ONCOL, Jg. 22, Nr. 6, 6, S. 646-655. <http://www.ncbi.nlm.nih.gov/pubmed/20805748?dopt=Citation>

APA

Bacher, U., Schnittger, S., & Haferlach, T. (2010). Molecular genetics in acute myeloid leukemia. CURR OPIN ONCOL, 22(6), 646-655. [6]. http://www.ncbi.nlm.nih.gov/pubmed/20805748?dopt=Citation

Vancouver

Bacher U, Schnittger S, Haferlach T. Molecular genetics in acute myeloid leukemia. CURR OPIN ONCOL. 2010;22(6):646-655. 6.

Bibtex

@article{258d6b819619414787cf1ff53fc36553,
title = "Molecular genetics in acute myeloid leukemia.",
abstract = "Acute myeloid leukemia (AML) is a highly heterogeneous disorder being composed of various genetically defined subtypes. In recent years, molecular research provided the basis for a more differentiated characterization of AML patients, for example, of the large subgroup with normal karyotypes. This review summarizes the current status of molecular diagnostics in AML and refers to the diagnostic techniques being most suitable for the individual markers.",
author = "Ulrike Bacher and Susanne Schnittger and Torsten Haferlach",
year = "2010",
language = "Deutsch",
volume = "22",
pages = "646--655",
number = "6",

}

RIS

TY - JOUR

T1 - Molecular genetics in acute myeloid leukemia.

AU - Bacher, Ulrike

AU - Schnittger, Susanne

AU - Haferlach, Torsten

PY - 2010

Y1 - 2010

N2 - Acute myeloid leukemia (AML) is a highly heterogeneous disorder being composed of various genetically defined subtypes. In recent years, molecular research provided the basis for a more differentiated characterization of AML patients, for example, of the large subgroup with normal karyotypes. This review summarizes the current status of molecular diagnostics in AML and refers to the diagnostic techniques being most suitable for the individual markers.

AB - Acute myeloid leukemia (AML) is a highly heterogeneous disorder being composed of various genetically defined subtypes. In recent years, molecular research provided the basis for a more differentiated characterization of AML patients, for example, of the large subgroup with normal karyotypes. This review summarizes the current status of molecular diagnostics in AML and refers to the diagnostic techniques being most suitable for the individual markers.

M3 - SCORING: Zeitschriftenaufsatz

VL - 22

SP - 646

EP - 655

IS - 6

M1 - 6

ER -